Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC

Combining sacituzumab tirumotecan (sac-TMT; MK-2870/SKB264) with pembrolizumab (Keytruda) demonstrated promising activity and a manageable safety profile in a small cohort of patients with previously treated metastatic castration-resistant…